MoneyWorks4Me

Hester Biosciences Board to consider Dividend

10 May 2013 Evaluate

Hester Biosciences has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2013, to consider the audited financial result for the year ended on March 31, 2013 and declaration of dividend.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.20
Dr. Reddys Labs. 1212.50
Cipla 1373.35
Lupin 2093.60
Zydus Lifesciences 1159.60
View more..